Sopharma AD (SPH.WA) Stock Analysis & Winston Score

Sopharma AD is a Bulgarian pharmaceutical company that makes and sells medicines. It produces generic drugs — cheaper versions of brand-name medications — as well as over-the-counter health products. Its main customers are pharmacies, hospitals, and healthcare distributors, primarily across Eastern Europe and the former Soviet states. The company earns money by manufacturing and distributing pharmaceutical products, selling them through wholesale and retail pharmacy networks. Sopharma operates mainly in Bulgaria, Ukraine, Russia, and other Eastern European markets, making it one of the larger pharmaceutical producers in the Balkans. Its regional manufacturing base and established distribution network give it a cost advantage over Western competitors in these markets. The key growth driver is expanding its product portfolio and distribution reach across emerging European markets, but the company faces meaningful risk from its exposure to geopolitically unstable regions, including Ukraine and Russia, where currency swings and regulatory changes can quickly affect revenues.